Surmodics Inc (NAS:SRDX)

$ 39.67 -0.01 (-0.03%) Market Cap: 567.05 Mil Enterprise Value: 560.32 Mil PE Ratio: 0 PB Ratio: 4.78 GF Score: 70/100

Q2 2024 Surmodics Inc Earnings Call Transcript
May 01, 2024

$33.33 (+29.74%)

Earnings
Q1 2024 Surmodics Inc Earnings Call Transcript
Feb 01, 2024

$32.43 (-7.90%)

Earnings
Q4 2023 Surmodics Inc Earnings Call Transcript
Nov 08, 2023

$33.24 (+7.36%)

Earnings
Surmodics Inc at Sidoti Virtual Micro-Cap Conference Transcript
Aug 16, 2023
Q3 2023 Surmodics Inc Earnings Call Transcript
Aug 02, 2023

$32.6 (+4.55%)

Earnings
Surmodics Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Q2 2023 Surmodics Inc Earnings Call Transcript
Apr 26, 2023

$24.23 (+1.55%)

Earnings
Surmodics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 20, 2023
Q1 2023 Surmodics Inc Earnings Call Transcript
Feb 06, 2023

$30.19 (+0.80%)

Earnings
Q4 2022 Surmodics Inc Earnings Call Transcript
Nov 09, 2022

$32.05 (-6.61%)

Earnings
Q3 2022 Surmodics Inc Earnings Call Transcript
Jul 27, 2022

$35.81 (-5.74%)

Earnings
Q2 2022 Surmodics Inc Earnings Call Transcript
Apr 27, 2022

$40.05 (-0.84%)

Earnings
Q1 2022 Surmodics Inc Earnings Call Transcript
Feb 03, 2022

$40.68 (-11.74%)

Earnings
Q4 2021 Surmodics Inc Earnings Call Transcript
Nov 10, 2021

$51 (-9.43%)

Earnings
Q3 2021 Surmodics Inc Earnings Call Transcript
Aug 04, 2021

$54.73 (-2.91%)

Earnings
Q2 2021 Surmodics Inc Earnings Call Transcript
Apr 28, 2021

$59.1 (+0.25%)

Earnings
Surmodics Inc Annual Shareholders Meeting Transcript
Feb 11, 2021
Q1 2021 Surmodics Inc Earnings Call Transcript
Feb 09, 2021

$52.19 (+13.98%)

Earnings
Q4 2020 Surmodics Inc Earnings Call Transcript
Nov 04, 2020

$38.36 (+3.04%)

Earnings
Q3 2020 Surmodics Inc Earnings Call Transcript
Aug 05, 2020

$48.48 (+3.02%)

Earnings
Q2 2020 Surmodics Inc Earnings Call Transcript
Apr 29, 2020

$38.39 (+4.18%)

Earnings
Surmodics Inc Annual Shareholders Meeting Transcript
Feb 13, 2020
Q1 2020 Surmodics Inc Earnings Call Transcript
Feb 05, 2020

$40.57 (+2.71%)

Earnings
Q4 2019 Surmodics Inc Earnings Call Transcript
Oct 31, 2019

$47.51 (+1.24%)

Earnings
Q3 2019 Surmodics Inc Earnings Call Transcript
Jul 31, 2019

$41.7 (+0.97%)

Earnings
Surmodics Inc at Jefferies Healthcare Conference Transcript
Jun 04, 2019
Q2 2019 Surmodics Inc Earnings Call Transcript
May 01, 2019

$43.04 (-0.92%)

Earnings
Surmodics Inc at Needham Healthcare Conference Transcript
Apr 10, 2019
Surmodics Inc Annual Shareholders Meeting Transcript
Feb 13, 2019

Surmodics Inc at Sidoti Virtual Micro-Cap Conference Transcript

Aug 16, 2023 / 02:45PM GMT

Release Date Price: $37.67 (+0.37%)

Transcript

Jim Sidoti

Sidoti & Company, LLC - Analyst

Hi, good morning and welcome to the Sidoti events virtual investor conference. Next up is Surmodics, representing the company is the CFO, Tim Arens. We have about 30 minutes for the presentation. There should be some time at the end for Q&A. (Operator Instructions)

It's all yours, Tim.

Tim Arens

Surmodics, Inc. - SVP of Finance and Information Technology & CFO

Well great, thank you, Jim. And good morning and welcome to everybody joining us today. I promise you that we'll have some time for questions. So let's start with the first half with the Safe Harbor statement. I'll bring your attention here. This describes inherent probabilities and forward-looking statements and risks.

Surmodics, let's talk a little bit about Surmodics today. Surmodics was founded in 1979 and is focused on driving innovation to improve the prevention and treatment of disease. We are a Nasdaq-listed and have been since 1998 and our current market cap is greater than $500 million. We have nearly 400 employees,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.